NASDAQ:DARE
Daré Bioscience, Inc. Stock News
$0.286
-0.0113 (-3.80%)
At Close: Apr 24, 2024
Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript
08:47pm, Thursday, 28'th Mar 2024
Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
08:00am, Thursday, 21'st Mar 2024
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at
Daré Bioscience, Inc. (DARE) Q3 2023 Earnings Call Transcript
09:56pm, Thursday, 09'th Nov 2023
Daré Bioscience, Inc. (NASDAQ:DARE ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Sabrina Martucci Johnson - President and CEO John Fair - Chief Commercial Office
Daré Bioscience to Host Second Quarter 2023 Financial Results and Company Update Conference Call and Webcast on August 10, 2023
08:00am, Thursday, 03'rd Aug 2023
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30
Daré Bioscience's 'female Viagra' could be first-in-category product: broker
04:26pm, Thursday, 13'th Jul 2023
Daré Bioscience could have a first-in-category product on its hands with its “female Viagra” offering, analysts at Dawson James believe. The women's health-focused biopharmaceutical company on Tu
Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems
05:30pm, Tuesday, 11'th Jul 2023
SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that the company's Chief Scientific Officer, David Friend, Ph
Daré Bioscience, Inc. (DARE) Q1 2023 Earnings Call Transcript
10:10pm, Thursday, 11'th May 2023
Daré Bioscience, Inc. (NASDAQ:DARE ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Sabrina Martucci Johnson – President and Chief Executive Officer John Fair – Chi
Daré Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023
08:00am, Thursday, 04'th May 2023
SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p
Dare Bioscience, Inc. (DARE) Q4 2022 Earnings Call Transcript
11:16pm, Thursday, 30'th Mar 2023
Dare Bioscience, Inc. (NASDAQ:DARE ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Sabrina Johnson - President & Chief Executive Officer Lisa Walters-Hoffert - Chief
Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023
08:00am, Thursday, 23'rd Mar 2023
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30
Daré Bioscience to Present at the 35th Annual Roth Conference
08:00am, Wednesday, 01'st Mar 2023
SAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, the company's President and C
All You Need to Know About Dare Bioscience, Inc. (DARE) Rating Upgrade to Strong Buy
01:33pm, Monday, 09'th Jan 2023
Dare Bioscience, Inc. (DARE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dare Bioscience, Inc. (DARE) Upgraded to Buy: What Does It Mean for the Stock?
05:00pm, Tuesday, 15'th Nov 2022 Zacks Investment Research
Dare Bioscience, Inc. (DARE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dare Bioscience, Inc. (DARE) Upgraded to Buy: What Does It Mean for the Stock?
01:33pm, Tuesday, 15'th Nov 2022
Dare Bioscience, Inc. (DARE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dare Bioscience, Inc. (DARE) Q3 2022 Earnings Call Transcript
08:45pm, Thursday, 10'th Nov 2022
Dare Bioscience, Inc. (NASDAQ:DARE ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Sabrina Johnson - President and Chief Executive Officer Lisa Walters-Hoffert - C
